Suppression and recovery of immunologic function after bone marrow transplantation.
Infections are common causes of death in patients undergoing bone marrow transplantation for aplastic anemia or leukemia. A better understanding of the immunologic recovery following marrow grafting may lead to clinical trials of which the goals are to improve immunologic reactivity and to decrease infection.
D000328:Adult; D000367:Age Factors; D000368:Aged; D016026:Bone Marrow Transplantation; D004137:Dinitrochlorobenzene / Q000276:immunology; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007108:Immune Tolerance; D007114:Immunization; D017053:Infection Control; D007376:Interleukin-2; D007938:Leukemia / Q000276:immunology / Q000628:therapy; D007958:Leukocyte Count; D008214:Lymphocytes / Q000276:immunology; D008875:Middle Aged; D012882:Skin Tests
D004137:Dinitrochlorobenzene; D007376:Interleukin-2